Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01289561 · ClinicalTrials.gov registry record · Phase 1

Combined Effects of Alcohol and Caffeine

A Phase 1 study, sponsored by Johns Hopkins University.

Completed
Registry status
Phase 1
Development phase
20
Enrollment target

NCT01289561: Completed Phase 1 study, sponsored by Johns Hopkins University.

NCT01289561 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01289561, a Phase 1 study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
Phase 1
Development phase
20 participants
Enrollment target

Study Summary

The purpose of this study is to investigate the effects of caffeine on the self-administration of alcohol. The study will also examine the combined effects of alcohol and caffeine on behavioral performance, participant ratings of behavioral performance, and self-reported subjective effects.

Interventions

  • DRUG Alcohol + Caffeine Beverage
  • DRUG Alcohol + Caffeine-placebo

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2011-01
Est. Completion 2015-01
Phase Phase 1

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT01289561

The ClinicalTrials.gov registry entry for NCT01289561 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Alcohol + Caffeine Beverage is the first listed.

NCT01289561 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01289561 about?

NCT01289561 is a clinical study titled "Combined Effects of Alcohol and Caffeine". The purpose of this study is to investigate the effects of caffeine on the self-administration of alcohol. The study will also examine the combined effects of alcohol and caffeine on behavioral performance, participant ratings of behavioral performance, and self-reported subjective effects.

What is the current status of trial NCT01289561?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2011-01. Estimated completion is 2015-01.

What interventions are being tested in trial NCT01289561?

The interventions under investigation include: Alcohol + Caffeine Beverage (DRUG), Alcohol + Caffeine-placebo (DRUG).

Who is sponsoring clinical trial NCT01289561?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.